GlaxoSmithKline PLCAdd to My Watchlist

GSK:USNew YorkIndustry: Medical-Drugs
  • 43.44
    Last
  • 0.15  -0.34%
    Today's Change
  • 43.59
    Previous Close
  • Today
     
    41.19
    49.24
    52 Week Low - High
8:04 pm ET 7/31/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding2 billion
Market Cap$106 billion
Return on Equity ttm149.51%
Last Dividend$0.59
Dividend Yield ttm5.86
Relative Dividend Yield benchmark--
Dividend Ex-Date8/12/15
Dividend Pay Date10/1/15
Earnings
EPS: Year Actual ttm--
EPS: Year Est. 12/15 ttm1.540
 
EPS: Quarterly Actual 6/15 --
EPS: Quarterly Est. 9/15 0.41
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-49.07
Company Description
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
Revenue$23 billion
Net Income$3 billion
Total Assets$41 billion
Employees98,702
Web Sitewww.gsk.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!